Insider · CIK 0001303827
Lampo Craig A
cfoofficer
Files at APH (AMPHENOL CORP /DE/). First filing Oct 31, 2024, latest Nov 7, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $32M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 57Moderate | sell 5 | APH AMPHENOL CORP /DE/ | $21M | 300,000 | -49% | - | |
| 57Moderate | sell 5 | APH AMPHENOL CORP /DE/ | $10M | 150,000 | -41% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | APH AMPHENOL CORP /DE/ | GGift Class A Common Stock | -160,000 | $0.00 | $0 | 158,116 | Dec 4, 2024 |
| Dec 3, 2024 | APH AMPHENOL CORP /DE/ | GGift Class A Common Stockindirect: By Craig A. Lampo 2024 GRAT #2 | +160,000 | $0.00 | $0 | 160,000 | Dec 4, 2024 |
| Nov 6, 2024 | APH AMPHENOL CORP /DE/ | MOption exercise Class A Common Stock | +400,000 | $18.23 | $7.3M | 618,116 | Nov 7, 2024 |
| Nov 6, 2024 | APH AMPHENOL CORP /DE/ | SOpen-market sale Class A Common Stock | -300,000 | $71.56 | $21M | 318,116 | Nov 7, 2024 |
| Nov 6, 2024 | APH AMPHENOL CORP /DE/ | MOption exercise Stock Optionderivative | -400,000 | $0.00 | $0 | 400,000 | Nov 7, 2024 |
| Oct 29, 2024 | APH AMPHENOL CORP /DE/ | MOption exercise Class A Common Stock | +150,000 | $14.50 | $2.2M | 368,116 | Oct 31, 2024 |
| Oct 29, 2024 | APH AMPHENOL CORP /DE/ | SOpen-market sale Class A Common Stock | -150,000 | $68.76 | $10M | 218,116 | Oct 31, 2024 |
| Oct 29, 2024 | APH AMPHENOL CORP /DE/ | MOption exercise Stock Optionderivative | -150,000 | $0.00 | $0 | 0 | Oct 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.